PNU 166148 in Treating Patients With Metastatic Solid Tumors
NCT00004076
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG:
mureletecan
Sponsor
University of Glasgow